LIBREDE
Biotech · Private
Yeast-based platform for scalable production of cannabidiol (CBD)
- Grants
- $3.9M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 5 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Automated nanopore platform for microRNA based diagnostics | $224,637 | |
| Federal grant | Department of Health and Human Services · Phase I · Automated nanopore platform for microRNA based diagnostics | $224,637 | |
| Federal grant | Department of Health and Human Services · Phase I · Expression of Phytocannabinoids in Yeast: a High Yield Platform for Low Abundance Natural Products | $221,374 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a cannabinoid yeast factory: improving geranyl pyrophosphate production through metabolic engineering | $224,920 | |
| Federal grant | Department of Health and Human Services · Phase II · Expression of Phytocannabinoids in Yeast: a High Yield Platform for Low Abundance Natural Products (Phase II) | $622,223 | |
| Federal grant | Department of Health and Human Services · Phase II · Expression of Phytocannabinoids in Yeast: a High Yield Platform for Low Abundance Natural Products (Phase II) | $1,498,047 | |
| Federal grant | Department of Health and Human Services · Phase II · Expression of Phytocannabinoids in Yeast: a High Yield Platform for Low Abundance Natural Products (Phase II) | $875,824 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2873 | Q-State Biosciences, Inc. | — | — |
| 2874 | NEUCORE BIO, INC. | — | — |
| 2875 | PROMILEAD, LLC | — | — |
| 2876 | LIBREDE | — | — |
| 2877 | DELINEATE INC | — | — |
| 2878 | SPECTRAL THERAPEUTICS, INC. | — | — |
| 2879 | CYPRESS BIOPHARMA, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Production of Cannabinoids in Yeastgranted
- Production of Cannabigerolic Acid in Yeastgranted
- Production Of Tetrahydrocannabinolic Acid In Yeastgranted
- Production of Cannabidiolic Acid in Yeastgranted
- Production Of Cannabinoids In Yeastgranted
- Production Of Cannabinoids In Yeastapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.